Department of Gastroenterology and Hepatology, Center for Lysosomal and Metabolic Diseases, Erasmus Medical Center, Rotterdam, The Netherlands.
Department of Pathology, Center for Lysosomal and Metabolic Diseases, Erasmus Medical Center, Rotterdam, The Netherlands.
J Gastrointestin Liver Dis. 2015 Dec;24(4):515-8. doi: 10.15403/jgld.2014.1121.244.had.
Glycogen storage diseases (GSDs) are a group of inherited metabolic disorders characterized by accumulation of abnormal glycogen in muscle or liver or both. Specific hepatic complications include liver adenomas and hepatocellular carcinoma (HCC). Hepatocellular carcinomas described in GSD type I are often due to the degeneration of liver adenomas. Hepatocellular carcinoma in GSD type III, however, is rare and is thought to be associated with underlying cirrhosis.We present the case of a 63-year old male who was admitted for assessment of suitability for liver transplantation because of development of recurrent HCC in the presence of multiple liver adenomas. A diagnosis of GSD type III was made in this patient without underlying cirrhosis or metabolic disturbances resembling GSD. This case report is the first documentation of HCC development in an asymptomatic, non-cirrhotic patient with GSD type III. This raises the possibility that in GSD type III, the adenoma - carcinoma sequence can occur as it is also seen in GSD type I. Physicians taking care of GSD patients should be aware of this and some form of surveillance for cirrhosis and HCC should be considered. Also male patients with adenomas should have a thorough workup to reveal any underlying disease such as GSD.
糖原贮积病(GSDs)是一组遗传性代谢紊乱,其特征是肌肉或肝脏或两者中异常糖原的积累。特定的肝脏并发症包括肝腺瘤和肝细胞癌(HCC)。GSD 型 I 中描述的肝细胞癌通常是由于肝腺瘤的变性。然而,GSD 型 III 中的肝细胞癌很少见,并且被认为与潜在的肝硬化有关。我们介绍了一名 63 岁男性的病例,他因多发性肝腺瘤存在而复发性 HCC 而入院评估肝移植的适宜性。该患者未患有肝硬化或代谢紊乱,类似于 GSD,被诊断为 GSD 型 III。该病例报告是首例无症状、非肝硬化的 GSD 型 III 患者发生 HCC 的记录。这提出了这样一种可能性,即在 GSD 型 III 中,腺瘤 - 癌序列可能像在 GSD 型 I 中那样发生。照顾 GSD 患者的医生应该意识到这一点,并应考虑进行某种形式的肝硬化和 HCC 监测。此外,有腺瘤的男性患者应进行彻底的检查,以发现任何潜在的疾病,如 GSD。